Search   
MSDS  : Carbamic acid, hydroxy-, ethyl ester
CAS  : 589-41-3
SYNONYMS  : * Ethylester kyseliny N-hydroxykarbaminove * Ethyl N-hydroxycarbamate * Hydroxycarbamic acid ethyl ester * N-Hydroxy ethyl carbamate * N-Hydroxyurethan * N-Hydroxyurethane * NHU * NSC-83629 * NSC-71045 * SQ 16819
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : FB1750000
CHEMICAL NAME : Carbamic acid, hydroxy-, ethyl ester
CAS REGISTRY NUMBER : 589-41-3
BEILSTEIN REFERENCE NO. : 1747529
REFERENCE : 4-03-00-00168 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 38
MOLECULAR FORMULA : C3-H7-N-O3
MOLECULAR WEIGHT : 105.11
WISWESSER LINE NOTATION : QMVO2
COMPOUND DESCRIPTOR : Tumorigen
Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Ethylester kyseliny N-hydroxykarbaminove
* Ethyl N-hydroxycarbamate
* Hydroxycarbamic acid ethyl ester
* N-Hydroxy ethyl carbamate
* N-Hydroxyurethan
* N-Hydroxyurethane
* NHU
* NSC-83629
* NSC-71045
* SQ 16819

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ADTEAS Advances in Teratology. (New York, NY) V.1-5, 1966-72.
Discontinued. Volume(issue)/page/year: 3,181,1968

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 500 mg/kg
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
RRCRBU Recent Results in Cancer Research. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965-
Volume(issue)/page/year: 52,29,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 8 gm/kg/8W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Sense Organs and Special Senses (Eye) - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
43,749,1969

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2400 mg/kg/2W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
29,2184,1969

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Unreported
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1 mg/kg
female 21 day(s) after conception
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Reproductive - Tumorigenic effects - transplacental tumorigenesis
Lungs, Thorax, or Respiration - tumors
REFERENCE :
40YJAX "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks
In New Drugs, Proceedings of the Symposium on Toxicological Testing for
Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague,
Czechoslovakia, Univerzita Karlova, 1979 Volume(issue)/page/year:
-,141,1979

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
VOONAW Voprosy Onkologii. Problems of Oncology. For English translation,
see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10,
1928-37; V.1- 1955- Volume(issue)/page/year: 15(2),66,1969

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2400 mg/kg/4W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
29,2184,1969

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5800 mg/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
Blood - leukemia
REFERENCE :
IJCNAW International Journal of Cancer. (International Union Against
Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966-
Volume(issue)/page/year: 4,318,1969

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2900 mg/kg/5W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Lungs, Thorax, or Respiration - tumors
Blood - leukemia
REFERENCE :
IJCNAW International Journal of Cancer. (International Union Against
Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966-
Volume(issue)/page/year: 4,318,1969

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE : 738 mg/kg
SEX/DURATION : female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in
number of implants per female; total number of implants per corpora lutea)
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB223-160

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 252 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
27,1696,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 252 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial
(including nose and tongue)
Reproductive - Specific Developmental Abnormalities - body wall
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
27,1696,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 1009 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
27,1696,1967

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 10 mmol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 151,201,1985

TYPE OF TEST : DNA repair
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 10 mg/L
REFERENCE :
JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC)
V.61-79, 1978-87. For publisher information, see JNCIEQ.
Volume(issue)/page/year: 62,873,1979

TYPE OF TEST : DNA damage
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 200 mmol/L
REFERENCE :
BBACAQ Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211,
1000 AE Amsterdam, Netherlands) V.1- 1947- Volume(issue)/page/year:
312,1,1973

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Bacteria - Bacillus subtilis
DOSE/DURATION : 10 mmol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 4,517,1967

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human HeLa cell
DOSE/DURATION : 1320 umol/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
14,205,1965

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Human Leukocyte
DOSE/DURATION : 333 umol/L/48H
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
25,980,1965

TYPE OF TEST : Unscheduled DNA synthesis
TEST SYSTEM : Rodent - rat Liver
DOSE/DURATION : 10 mmol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 145,201,1985

TYPE OF TEST : Sister chromatid exchange
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 400 mg/kg
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 126,159,1984

TYPE OF TEST : Morphological transformation
TEST SYSTEM : Rodent - mouse Embryo
DOSE/DURATION : 10 ug/L
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
52,1167,1974

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - mouse Embryo
DOSE/DURATION : 50 umol/L
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
32,667,1964

TYPE OF TEST : Sister chromatid exchange
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 1100 umol/kg
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
41,4489,1981

TYPE OF TEST : Sister chromatid exchange
ROUTE OF EXPOSURE : Unreported
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 400 mg/kg
REFERENCE :
BANRDU Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring
Harbor, NY 11724) V.1- 1979- Volume(issue)/page/year: 13,293,1982

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 20 mmol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 152,225,1985

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - hamster Cells - not otherwise specified
DOSE/DURATION : 50 umol/L
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
32,667,1964

TYPE OF TEST : Sister chromatid exchange
ROUTE OF EXPOSURE : Unreported
TEST SYSTEM : Rodent - hamster
DOSE/DURATION : 400 mg/kg
REFERENCE :
BANRDU Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring
Harbor, NY 11724) V.1- 1979- Volume(issue)/page/year: 13,293,1982

TYPE OF TEST : Sister chromatid exchange
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 5 gm/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 3,1437,1982

TYPE OF TEST : Sister chromatid exchange
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - hamster
DOSE/DURATION : 400 mg/kg
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 126,159,1984

TYPE OF TEST : Mutation in mammalian somatic cells
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 10 mg/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 3,1437,1982

TYPE OF TEST : DNA damage
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 200 mmol/L
REFERENCE :
BBACAQ Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211,
1000 AE Amsterdam, Netherlands) V.1- 1947- Volume(issue)/page/year:
312,1,1973

TYPE OF TEST : DNA damage
TEST SYSTEM : Bird - chicken Embryo
DOSE/DURATION : 200 mmol/L
REFERENCE :
BBACAQ Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211,
1000 AE Amsterdam, Netherlands) V.1- 1947- Volume(issue)/page/year:
312,1,1973

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Positive: Cell transform.-mouse embryo

EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-human lymphocyte

EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus; E coli polA
without S9

EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat

EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Carbamic acid, (2-(hexyloxy)phenyl)-,3-(dimethylamino)bicyclo(2.2.2)oct-2-yl ester,monohydrochloride, cis- 71746-31-1
Carbamic acid, cyclohexyl-,1-(4-fluorophenyl)-1-phenyl-2-propynyl ester 10104-58-2
Carbamic acid, (2-(hexyloxy)phenyl)-,3-(dimethylamino)bicyclo(2.2.2)oct-2-yl ester,monohydrochloride, trans- 71746-30-0
Carbamic acid, (3-(hexyloxy)phenyl)-,3-(dimethylamino)bicyclo(2.2.2)oct-2-yl ester,monohydrochloride, trans- 71746-36-6
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(dimethylamino)cyclohexyl ester, monohydrochloride,trans- 71746-32-2
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(dimethylamino)-1,1-dimethylethyl ester,monohydrochloride 142682-44-8
Carbamic acid, (2-(hexyloxy)phenyl)-,1-((dimethylamino)methyl)cyclohexyl ester,hydrochloride 113873-73-7
Carbamic acid, (2-(hexyloxy)phenyl)-,5-(dimethylamino)tricyclo(4.4.0.0(sup 3,8))dec- 4-ylester, monohydrochloride, stereoisomer 71746-37-7
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(2-ethoxyethoxy)-1-((hexahydro-1H-azepin-1-yl)methyl) ethyl ester, ethanedioate (1:1) 71746-37-7
Carbamic acid, (2-(hexyloxy)phenyl)-,1-((2-ethoxyethoxy)methyl)-2-(1-piperidinyl) ethylester, ethanedioate (1:1) 71746-37-7
Carbamic acid, (2-(hexyloxy)phenyl)-,1-((2-ethoxyethoxy)methyl)-2-(1-pyrrolidinyl) ethylester, ethanedioate (1:1) 71746-37-7
Carbamic acid, (2-(hexyloxy)phenyl)-,2-((4-methyl-1-piperazinyl)methyl)cyclohexyl ester,dihydrochloride, monohydrate, trans- 130533-76-5
Carbamic acid,(1-(2-((cyclohexylmethylamino)methyl)-4,6-dibromocarbaniloyl)- 2-mercaptoethyl)-, benzyl ester,hydrochloride, (R)- 97290-51-2
Carbamic acid, (3-(hexyloxy)phenyl)-,1-methyl-2-(1-piperidinyl)ethyl ester,monohydrochloride 40712-76-3
Carbamic acid, (4-(hexyloxy)phenyl)-,1-methyl-2-(1-piperidinyl)ethyl ester,monohydrochloride 42438-19-7
Carbamic acid, (3-(hexyloxy)phenyl)-,1-methyl-2-(1-pyrrolidinyl)ethyl ester,monohydrochloride 41017-73-6
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(4-morpholinyl)ethyl ester, monohydrochloride 112922-98-2
Carbamic acid, (3-(hexyloxy)phenyl)-,2-(morpholino)ethyl ester, monohydrochloride 112922-99-3
Carbamic acid, (4-(hexyloxy)phenyl)-,2-(morpholino)ethyl ester, monohydrochloride 112923-00-9
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(4-morpholinylmethyl)cyclohexyl ester,monohydrochloride, mixed isomer 112923-00-9
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(4-morpholinylmethyl)phenyl ester,monohydrochloride 130533-79-8
Carbamic acid, (4-(hexyloxy)phenyl)-,2-(1-piperidinyl)cyclohexyl ester, hydrochloride,cis- 38205-35-5
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(1-piperidinyl)ethyl ester, monohydrochloride 55792-18-2
Carbamic acid, (2-chloroethyl)-,2-methyl-2-propyltrimethylene ester 25648-67-3
Carbamic acid, ((cyclohexyloxy)thio)methyl-,2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester 86627-66-9
Carbamic acid, (3-(hexyloxy)phenyl)-,2-(1-piperidinyl)ethyl ester, monohydrochloride 55792-19-3
Carbamic acid, (4-(hexyloxy)phenyl)-,2-(1-piperidinyl)ethyl ester, monohydrochloride 55792-20-6
Carbamic acid, (2-(hexyloxy)phenyl)-,1-(1-piperidinylmethyl)-2-propoxyethyl ester,ethanedioate (1:1) 143503-37-1
Carbamic acid, (3-(hexyloxy)phenyl)-,1-(1-piperidinylmethyl)-2-propoxyethyl ester,ethanedioate (1:1) 143503-41-7
Carbamic acid, (2-(hexyloxy)phenyl)-,2-(1-piperidinyl)-1-(1-piperidinylmethyl)ethyl ester,dihydrochloride 113873-30-6
Carbamic acid, (3-(hexyloxy)phenyl)-,2-(1-piperidinyl)-1-(1-piperidinylmethyl)ethyl ester,dihydrochloride 113873-34-0
Carbamic acid, (2-(hexyloxy)phenyl)-,1-(propoxymethyl)-2-(1-pyrrolidinyl)ethyl ester,ethanedioate (1:1) 143503-29-1
Carbamic acid, (3-(hexyloxy)phenyl)-,1-(propoxymethyl)-2-(1-pyrrolidinyl)ethyl ester,ethanedioate (1:1) 143503-33-7
Carbamic acid, ((hexyloxy)sulfinyl)methyl-,2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester 77248-43-2
Carbamic acid, ((hexyloxy)thio)methyl-,2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester 86627-65-8
Carbamic acid, N-cyclohexyl-,1-phenyl-1-(3,4-xylyl)-2-propynyl ester 20921-50-0
Carbamic acid,((3-alpha,5-alpha,17-alpha)-3-hydroxyandrostan-17-yl)-, methyl ester 126054-49-7
Carbamic acid,((3-alpha,5-alpha,17-beta)-3-hydroxyandrostan-17-yl)-, methyl ester 126054-48-6
Carbamic acid,((3-beta,5-alpha,17-alpha)-3-hydroxyandrostan-17-yl)-, methyl ester 126054-46-4
Carbamic acid,((3-beta,5-alpha,17-beta)-3-hydroxyandrostan-17-yl)-,methyl ester 126054-45-3
Carbamic acid, hydroxy-, benzyl ester 3426-71-9
Carbamic acid, (3-hydroxycrotonyl)methyl-, ethylester, ester with diethylphosphate 3426-71-9
Carbamic acid, (3-hydroxycrotonyl)methyl-, ethylester, ester with dimethylphosphate 3426-71-9
Carbamic acid, 2-(2-(hydroxyethylamino)ethyl)thio- 90533-43-0
Carbamic acid,(4-(((2-hydroxyethyl)amino)sulfonyl)phenyl)-, methylester 81865-14-7
Carbamic acid, hydroxy-, ethyl ester 589-41-3
Carbamic acid,(3-(4-(cyclopentylthio)-2-(((dimethylamino)acetyl)amino)phenyl)-4-oxo-2- thiazolidinylidene)-, methylester 63753-42-4
Carbamic acid, 2-hydroxyethyl ester 5395-01-7
Carbamic acid, (2-hydroxyethyl)-, ester with5-(1-aziridinyl)-1-ethyl-3-(hydroxymethyl)-2,6-dimethylindole-4,7-dione 5904-24-5
Carbamic acid, hydroxy-, ethyl ester, monosodium salt 54149-38-1

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net